IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CARPO, MARINELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.148
NA - Nord America 4.757
AS - Asia 2.866
SA - Sud America 289
OC - Oceania 81
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.452
GB - Regno Unito 3.117
IT - Italia 1.563
CN - Cina 1.032
SE - Svezia 720
DE - Germania 620
JP - Giappone 443
TR - Turchia 399
KR - Corea 362
FR - Francia 299
IN - India 295
IE - Irlanda 275
RU - Federazione Russa 246
UA - Ucraina 240
CA - Canada 231
FI - Finlandia 194
NL - Olanda 189
ES - Italia 156
EU - Europa 149
VN - Vietnam 123
PL - Polonia 121
GR - Grecia 98
BR - Brasile 87
AU - Australia 75
CO - Colombia 73
DK - Danimarca 73
AR - Argentina 66
MX - Messico 51
BE - Belgio 50
CH - Svizzera 46
ID - Indonesia 39
RO - Romania 39
SG - Singapore 37
AT - Austria 34
CL - Cile 34
TW - Taiwan 23
PT - Portogallo 20
TH - Thailandia 18
HK - Hong Kong 17
ZA - Sudafrica 15
PE - Perù 14
BD - Bangladesh 13
IR - Iran 12
TN - Tunisia 12
IL - Israele 9
UY - Uruguay 9
MA - Marocco 8
RS - Serbia 8
LB - Libano 6
NZ - Nuova Zelanda 6
PH - Filippine 6
SA - Arabia Saudita 6
SI - Slovenia 6
DZ - Algeria 5
EG - Egitto 5
GT - Guatemala 5
HR - Croazia 5
HU - Ungheria 5
LY - Libia 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
LT - Lituania 4
MY - Malesia 4
NO - Norvegia 4
EC - Ecuador 3
IQ - Iraq 3
JO - Giordania 3
MQ - Martinica 3
PK - Pakistan 3
PR - Porto Rico 3
CU - Cuba 2
CY - Cipro 2
GF - Guiana Francese 2
IS - Islanda 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
SM - San Marino 2
BG - Bulgaria 1
BY - Bielorussia 1
GP - Guadalupe 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 16.341
Salva come PNG Salva come JPEG
Città #
Southend 2.864
Chandler 545
Seattle 514
Princeton 365
Milan 348
Dublin 273
Wilmington 266
Beijing 227
Redmond 197
Redwood City 172
Toronto 143
Nanjing 142
Ashburn 141
Sakarya 139
Mountain View 131
Bengaluru 125
Des Moines 125
Tokyo 124
Jacksonville 114
Rome 113
Ann Arbor 96
Dearborn 90
Boardman 89
New York 82
Fairfield 81
Athens 75
Jinan 75
Eitensheim 70
Woodbridge 68
Warsaw 67
Shenyang 66
Houston 64
Hebei 56
Berlin 54
Bogotá 45
Paris 41
Serra 41
Frankfurt am Main 39
Buenos Aires 36
Dong Ket 36
Andover 35
Bitonto 35
Nanchang 35
Changsha 33
Ottawa 33
Verona 31
Duncan 29
San Diego 29
Istanbul 28
London 28
Shanghai 28
Phoenix 26
Prato 25
Barcelona 24
Brussels 24
Santiago 24
Grafing 22
Jiaxing 22
São Paulo 22
Tianjin 22
Turin 22
Zhengzhou 22
Guangzhou 21
Genova 20
Somerville 20
Chicago 19
Madrid 19
Hangzhou 18
Mumbai 18
Los Angeles 17
Ningbo 17
Taipei 17
Auburn Hills 16
Birmingham 16
Helsinki 16
Izmir 16
Sydney 16
Cambridge 14
Florence 14
Munich 14
Bochum 13
Chengdu 13
Fuzhou 13
Hefei 13
Copenhagen 12
Lima 12
Sunnyvale 12
Torino 12
Vienna 12
Padova 11
Philadelphia 11
Taizhou 11
Bangkok 10
Chiba 10
Messina 10
Nuremberg 10
Osaka 10
Saint Petersburg 10
Seoul 10
Amsterdam 9
Totale 9.470
Salva come PNG Salva come JPEG
Nome #
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 2.903
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 422
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 370
Impact of environmental factors and physical activity on disability and quality of life in CIDP 339
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 331
Rilevanza diagnostica degli anticorpi antinervo nelle neuropatie disimmuni 290
High tumor necrosis factor-alpha levels in cerebrospinal fluid of cobalamin-deficient patients 174
Caratterizzazione molecolare dei geni CLCN1, SCN4A, KCNJ2, CACNA1S in pazienti con canalopatie muscolari 163
Changes in vitamin B12 and tumour necrosis factor-a levels in cerebrospinal fluid of patients with different subtypes of multiple sclerosis 162
Stiff-Person Syndrome responding to intrathecal baclofen. 141
Survival motor neuron (SMN1 and SMN2) genes copy number in multifocal motor neuropathy 141
Polymorphisms of the TNF-alphagene in italian GBS patients 140
Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation 135
Neuroborreliosis mimicking a paraneoplastic syndrome 130
Changes in neuroimmunological pattern in IVIg treated-MMN patients : a long term follow up 125
Role of TNF-alpha in modulating GBS phenotype in Italian patients 124
A sporadic, atypical case of desminopathy: morphological and immunological characterization 123
A case-control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain-Barré syndrome in Western Lombardia 120
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 119
How-long is IVIg effective in multifocal motor neuropathy? 111
Long term efficacy of Rituximab in anti-MAG polyneuropathy 111
Molecular characterization of CLCN1, SCN4A, KCNJ2, CACNA1S genes in patients with muscle channelopathies. 111
How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? 111
Abnormal expression of cyclin-dependent kinase in an atypical case of desminopathy 110
Vascular Endotelial growth factor serum concentration and diabethic neuropathy 109
Multifocal motor neuropathy with an unusual clinical presentation 105
New abnormalities in the CSF of vitamin B12-deficient patients 103
Anti-GM1 IgM antibodies in motor neuron disease and neuropathy 101
Long term disability and social status change after Guillain-Barré syndrome 99
Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins 99
Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies 98
Electrophysiological parameters associated with reponse to IVIg in multifocal motor neuropathy 98
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation 98
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 97
A case control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in GBS: correlation with antecedent event and with clinical features 94
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 94
Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia 94
Autoimmunity in painful sensory neuropathy 94
Anti-ganglioside and anti-Campylobacter Jejuni (CJ) antibodies in Guillain-Barré syndrome (GBS): regional and temporal variability in Italian patients 94
Novel missense GARS gene mutation in an Italian family with hereditary distal motor neuropathy 93
Polyneuropathy in POEMS syndrome : role of angiogenic factors in the pathogenesis 93
An atypical case of desminopathy with abnormal expression of cyclin-dependent kinase 93
MONOCLONAL IGMK IN A PATIENT WITH MOTOR NEURON DISEASE BINDS TO GM1, GD1B, AND TO HIGH MOLECULAR CENTRAL NERVOUS SYSTEM-SPECIFIC GLYCOCONJUGATES 92
Painful sensory neuropathy and dysimmunity: is there a relation? 91
Treatment of multifocal motor neuropathy 90
Neurological complication in Celiac Disease: could have an autoimmune origin? 89
Electrophysiological parameters associated with reponse to IVIg in multifocal motor neuropathy 88
A case Control study of anti-ganglioside and anti-Campylobacter jejuni antibnodies in Guillain Barré syndrome in western Lombardia 88
VEGF and BFGF modulation are not involved in thalidomide-induced neuropathy 87
Anti-GM1 IgG antibodies in Guillain Barre' Syndrome 87
Anti-GD1a ganglioside antibodies in peripheral motor syndromes 86
Anti-sulfatide IgM antibodies in peripheral neuropathy 85
Long-term effect of Rituximab in antii-MAG polyneuropathy 84
The anti-oligosaccharide antibodies present in sera from patients with motor neuron disease and neuropathy recognize the N-glycolylneuraminic acid containing gangliotetrahexosyl oligosaccharide 83
Thalidomide-induced neuropathy is a distal axonopathy not due to VEGF inhibition 82
Gangliosides. Their role in clinical neurology 82
IgM reactivitry with a human neuroblsatoma cell line in patients with peripheral neurological disorders 82
Possible implementation of diagnostic tools in paraneoplastic neurological disorders. 81
Predictors of response to Rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M 81
Guillain-Barré syndrome : an Italian multicentre case-control study 81
Deterioration of multifocal motor neuropathy after plasma exchange 80
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 80
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor nuropathy (MMN) 80
Anti-GD1a antibodies in motor neuropathies 80
Anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain Barré syndrome: A case control study 80
IgM reactivity with a human neuroblastoma cell line in patients with peripheral neurological disorders 80
Lumbosacral root and facial nerve enhancement in Miller Fisher syndrome 80
Anti-GM1 IgM antibodies in motor neuron disase and other neurological diseases 80
Clinical and immunological study in neuropathy associated with IgG MGUS 80
Predictive value of anti-GM1 IgM and IgG antibodies for dysimmune neuropathies 79
Antecedent infections in Guillain Barré syndrome (GBS) in northern Italy: a clinical and serological case-control study 79
Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies 78
Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies 78
Effect of high-dose intravenous immunoglobulin (IVIg) on anti-glycolipid reactivity in multifocal motor neuropathy (MMN) 78
Anti-GM1 antibodies in CSF of patients with the Guillain Barre' Syndrome and motor neuropathy 78
Anti-GM1 antibodies in multifocal motor neuropathy : effect of intravenous immunoglobulin therapy 78
Anti-campylobacter jejuni lipopolysaccharide reactivity in multifocal motor neuropathy 77
Guillain Barre' Syndrome associated with high titers of anti-GM1 antibodies 77
Long-term efficacy of Rituximab in anti-MAG polyneuropathy 76
Proximal myotonic myopathy (PROMM) syndrome without CTG expansion: a new case 76
Anti-GM1 antibodies in CSF of Guillain Barre' Syndrome and motor neuropathy 76
Antigen specificity of the M-protein in 77 patients with neuropathy and IgM monoclonal gammopathy 76
Clinical and immunological features and response to IVIg in patients with clinically typical multifocal motor neuropathy but no overt conduction block 74
Clinical relevance of anti-GM1 IgM antibodies 74
Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy 74
Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy 74
Multifocal motor neuropathy: clinical and immunological features and response to IVIg therapy in patients with definite, probable or no overt conduction block 73
PROMM syndrome without trinucleotide repeat expansion 73
Anti-GM1 IgM antibodies in motor neuron disase and neuropathy 73
Detection of anti-glycolipid antibodies by a Dot-Blot analysis: could it be a valid alternative? 72
Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component 72
Different types of neuropathic pain in a large cohort of Italian patients with peripheral nervous system diseases 71
Long-term prognosis of post-attinic radiculoplexopathy under immunododulating therapies 71
Is campylobacter jejuni enteritis a risk factor for Guillain Barré sindrome in Italy? A case control study by western blot in northern Italy 71
Monoclonal IgMk in a patient with motor neuron disease binds to GM1, GD1b and to high molecular weight CNS-specific glyconjugates 71
Atypical anti-neuronal reactivity in neurological disorders : could have another role besides being paraneoplastic? 70
Long-term effect of intravenous immunoglobulin therapy (IVIg) in multifocal motor neuropathy (MMN) 70
Clinical and electrophysiological correlates of antiganglioside antibodies in Guillain-Barre syndrome 69
Are there immunologically treatable motor neuron diseases? 69
Neuropathy and monoclonal gammopathy 69
Totale 13.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019325 0 0 0 0 0 0 0 0 0 48 119 158
2019/20201.759 270 73 99 62 91 150 134 78 240 345 123 94
2020/20212.491 78 144 178 62 227 124 161 150 267 149 648 303
2021/20222.326 191 115 141 169 185 278 131 118 260 180 192 366
2022/20232.700 323 219 224 287 300 457 93 150 252 110 141 144
2023/20241.432 112 145 124 121 314 94 129 140 83 170 0 0
Totale 17.427